Wang Kaiding

WANG, Kaiding

Areas of Practice

Mr. Kaiding Wang is a corporate partner at King & Wood Mallesons. Mr. Wang focuses on cross-border mergers and acquisitions, foreign investment in China, corporate governance and general corporate law matters. He has worked on a range of transactions, including domestic and cross-border merger and acquisition transactions, private equity transactions, reorganizations, joint ventures and divestitures.

His recent representations include: Pfizer in its USD295 million joint venture with Hisun; Valin in its RMB11.5 billion two joint ventures with ArcelorMittal; Beijing Electric Vehicle in its joint venture with Siemens; Huayu in its joint venture with EW Group of Germany; Bank of China in its formation of two joint ventures in Beijing and Shanghai; Xiwang Foodstuffs in its USD730 million acquisition of Kerr Investment; BHAP in its EUR270 million acquisition of Inalfa; Shenhua in its acquisition of an exploration license in Australia; BAIC in its formation of an automobile manufacture joint venture in South Africa; Cardinal Health in its USD470 million acquisition of Zuellig Pharma. 

Mr. Kaiding Wang was recognized by Chambers in 2012 as one of China’s leading lawyers in Corporate/M&A category, and was recognized by Legal 500 in 2017 as one of the recommended lawyers in Corporate/M&A category. One of the joint-venture deals led by Mr. Wang was ranked as the Deal of the Year by China Business Law Journey in 2012, and one outbound-investment deal led by Mr. Wang won this laurel again in 2016.

Mr. Wang has authored several books, including Foreign Investment in China: Laws and Regulations with Selected Annotations, The Class Action in the United States, Law of Negotiable Instruments: Text and Cases and the U.S. Law on Sales of Goods. 

Work Experience

Mr. Wang joined the firm in 2007. Prior to joining King & Wood Mallesons, Mr. Wang worked as an associate at Yiwen and Zhonglun in Beijing from 1999 through 2006. Mr. Wang also worked as an international associate at United Technologies in Connecticut and a visiting attorney at Wachtell, Lipton, Rosen & Katz in New York. Mr. Wang was a lecturer at the University of International Business & Economics ("UIBE") School of Law from 1996 to 2010. 

Mr. Wang graduated from UIBE with a B.A. in Economics in 1993, an LL.M. in 1996 and a J.S.D. in 2006. He received an LL.M. degree from the University of Connecticut School of Law in 1998.

Mr. Wang is a member of the Beijing Lawyers Association and the China Law Society. Mr. Wang is an adjunct professor at UIBE School of Law, a trustee of Shen & Feng Foundation, a member of the executive committee of the China Law Academy of Lawyers and vice president of Beijing Chaoyang Friendship Association for Non-Party Intellectuals.

Mr. Wang’s working languages are Chinese and English.


Legal insights

It’s particularly worth noting that, the NDRC made restrictive interpretations with respect to the scope of sensitive projects.

10 July 2018

Regulation No. 11 will come into force on 1 March 2018.

26 December 2017

NDRC released the new Administrative Measures for Overseas Investment (draft for public comment) .

03 November 2017

NDRC proposes to further simplify Chinese outbound investment regulatory regime, this article summarizes major changes to the “road-pass” regime.

15 April 2016